Clinical Trial Update: Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update for a multimodal approach (chemotherapy, radiation, cetuximab, followed by surgery, then docetaxel and cetuximab) in esophageal or gastroes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Esophageal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-02-28